We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Dr. Srujan Gandham

Dr. Srujan Gandham profile page

Associate Director, Analytical Development

 at Aera Therapeutics


Srujan Gandham is the Associate Director of Analytical Development at Aera Therapeutics, where he leads analytical method development efforts focused on the characterization and quantitation of novel delivery systems (PNPs). Before joining Aera, Srujan was at Moderna, where he developed analytical methods for the characterization and impurity profiling of drug substances(mRNA) and drug product (LNP/mRNA). He played a key role in several of Moderna’s BLA and IND filings for various mRNA clinical programs, including mRNA-1273 (Moderna’s first COVID-19 vaccine). Srujan holds a PhD in Pharmaceutical Systems and Drug Delivery Systems from Northeastern University with research centered on understanding the contents of extracellular vesicles in mouse models of ovarian cancer.


Got a Question for Dr. Srujan Gandham?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Advertisement